Prema Abraham
Impact in
- Ophthalmology top 0.1%
- Retinal Diseases and Treatments
- Ocular Diseases and Behçet’s Syndrome
- Ocular Infections and Treatments
-
- Retinal Imaging and Analysis
- Retinal and Macular Surgery
Papers in
-
- Retinal Diseases and Treatments 38
-
- Retinal and Macular Surgery 2
- Co-authors
- Huibin Yue (2 shared papers)David M. Brown (3 shared papers)Susan Schneider (1 shared paper)Naveed K. Shams (1 shared paper)Tsontcho Ianchulev (1 shared paper)Carl D Regillo (1 shared paper)Clement K. Chan (12 shared papers)Quan Dong Nguyen (2 shared papers)
- Journals
- Ophthalmology (8 papers)JAMA Ophthalmology (6 papers)Retina (6 papers)Eye (4 papers)The Lancet (3 papers)
- Partner nations
- United StatesGermany
In The Last Decade
Prema Abraham
37 papers receiving 3.6k citations
Prema Abraham's Hit Papers
Peers
Comparison fields: 5 of 72
- Ophthalmology 3.6k
- Radiology, Nuclear Medicine and Imaging 239
- Pharmaceutical Science 71
- Immunology 79
- Molecular Biology 217
Countries citing papers authored by Prema Abraham
This map shows the geographic impact of Prema Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prema Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prema Abraham more than expected).
Fields of papers citing papers by Prema Abraham
This network shows the impact of papers produced by Prema Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prema Abraham. The network helps show where Prema Abraham may publish in the future.
Co-authors
The 25 scholars most cited alongside Prema Abraham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1 Hit paper breakdown → | 2008 | 728 |
| 2 | Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study Hit paper breakdown → | 2010 | 450 |
| 3 | Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration Hit paper breakdown → | 2019 | 433 |
| 4 | Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2 Hit paper breakdown → | 2010 | 343 |
| 5 | Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials Hit paper breakdown → | 2023 | 319 |
| 6 | 2009 | 283 | |
| 7 | Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial Hit paper breakdown → | 2023 | 230 |
| 8 | 2007 | 147 | |
| 9 | TENAYA and LUCERNE Hit paper breakdown → | 2024 | 125 |
| 10 | 2010 | 101 | |
| 11 | Faricimab Treat-and-Extend for Diabetic Macular Edema Hit paper breakdown → | 2023 | 97 |
| 12 | 2011 | 86 | |
| 13 | Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration Hit paper breakdown → | 2023 | 81 |
| 14 | Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial Hit paper breakdown → | 2024 | 75 |
| 15 | 2013 | 66 | |
| 16 | 2007 | 58 | |
| 17 | 2010 | 40 | |
| 18 | 2016 | 35 | |
| 19 | 2009 | 33 | |
| 20 | 2016 | 29 |
About Prema Abraham
Prema Abraham is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 40 papers that have together received 3.9k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (38 papers) and Retinal and Macular Surgery (2 papers). The work is most often cited by research in Ophthalmology (3.6k citations), Radiology, Nuclear Medicine and Imaging (239 citations), Pharmaceutical Science (71 citations), Immunology (79 citations) and Molecular Biology (217 citations). Prema Abraham has collaborated with scholars based in United States and Germany. Frequent co-authors include Huibin Yue, David M. Brown, Susan Schneider, Naveed K. Shams, Tsontcho Ianchulev, Carl D Regillo, Clement K. Chan, Quan Dong Nguyen, STEVEN G. LIN and David S. Boyer. Their work appears in journals such as Ophthalmology, JAMA Ophthalmology, Retina, Eye and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.